MedTrace Logo

Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study (ERASC1)

NCT03126058 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2018-04-30

No results posted yet for this study

Summary

This study is aimed to evaluate the safety of applying enhanced recovery after surgery for colorectal cancer.

Conditions

Interventions

PROCEDURE

enhanced recovery after surgery

Patients will undergo enhanced recovery after surgery programs.

Sponsors & Collaborators

  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Zhi-Wei JIANG · Jinling Hospital, Medical School of Nanjing University

  • Jian ZHAO · Jinling Hospital, Medical School of Nanjing University

  • Gang WANG · Jinling Hospital, Medical School of Nanjing University

  • Jiang LIU · Jinling Hospital, Medical School of Nanjing University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-21
Primary Completion
2018-08-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03126058 on ClinicalTrials.gov